Efficacy of Consolidation Therapy with Ponatinib 15mg on Treatment-Free Remission Rate in Patients with Chronic Myeloid Leukemia. Results of the Ponazero TrialLucía Pérez‐Lamas, Valentín García‐Gutiérrez, Juan Carlos Hernández‐Boluda et al.|Blood|2023Cited by 1
Remark: A phase II, open-label, multicenter study of orally administered romaciclib (RVU120) for the treatment of anemia in patients with lower-risk myelodysplastic neoplasms (LR-MDS)Uwe Platzbecker, Valeria Santini, Antonella Poloni et al.|Blood|2025Cited by 0